Opportunities Preloader

Please Wait.....

Report

Home Healthcare Market Report and Forecast 2025-2034

Market Report I 2025-06-20 I 400 Pages I EMR Inc.

The global home healthcare market was valued at USD 393.86 Billion in 2024. It is expected to grow at a compound annual growth rate (CAGR) of 8.70% from 2025 to 2034, reaching USD 907.06 Billion by 2034. The rising healthcare costs and the demand for cost-effective alternatives are key drivers of market growth. Advances in virtual care and the expanding remote care industry contribute to the increasing adoption of home-based healthcare solutions. Technological innovations, including AI-driven patient monitoring, telehealth platforms, and smart medical devices, are enhancing patient management and reducing hospital visits. The aging population and the prevalence of chronic diseases further accelerate the demand for home healthcare services. Additionally, healthcare providers and insurers are focusing on minimizing healthcare costs by promoting home-based treatments, improving accessibility, and enhancing patient outcomes.

The U.S. home healthcare market is experiencing significant growth due to the rising adoption of acute care at-home programs. These initiatives provide hospital-level treatment in home settings, improving patient comfort and reducing pressure on healthcare facilities. The growing emphasis on reduction in cost of care has encouraged healthcare providers to integrate home-based solutions, leading to lower hospitalization rates and better resource utilization. The increasing preference for home-based care is expected to sustain market growth.

Home Healthcare Market Trends

The increasing geriatric population is emerging as a significant trend in the home healthcare market. Aging individuals require continuous care and support, driving demand for home-based medical solutions. The growing senior demographic benefits from specialized services, including chronic disease management and rehabilitation. Health systems and caregivers are focusing on in-home services to enhance patient comfort and reduce hospital stays. This trend has led to increased investments in tailored healthcare technologies and community-based care initiatives. As the elderly population expands, market players are strategically aligning offerings to cater to the evolving needs of seniors, ensuring better quality of life and improved health outcomes overall.

Technological advancements are reshaping the home healthcare market by offering improved solutions. Innovations in medical devices, telehealth, and remote monitoring systems have enhanced patient care at home. These advancements enable real-time data analysis, proactive health management, and timely interventions, thereby reducing hospitalizations. Developers are integrating artificial intelligence and cloud computing to deliver personalized care and streamline operational efficiency. The industry is witnessing robust investments in research and development to drive further innovation. As technology evolves, it facilitates better patient outcomes, enhances provider capabilities, and supports a more efficient healthcare delivery model in the home setting.

The market trend toward cost-effective devices is influencing product strategies in the home healthcare sector. Consumers and providers are increasingly seeking affordable medical solutions that maintain high quality and performance. Cost-effectiveness drives the adoption of devices that reduce overall healthcare expenditures without compromising care standards. Manufacturers are focusing on streamlined production and innovative materials to lower costs while improving functionality. This trend encourages competitive pricing, which in turn expands market accessibility for a broader patient base. As healthcare budgets tighten, the emphasis on cost-effective devices continues to grow, ensuring sustainable and inclusive home healthcare delivery.

Home Healthcare Market Concentration & Characteristics

The home healthcare market had a high degree of innovation due to advancements in telehealth, AI-driven monitoring, and remote patient care. Increased investments in smart medical devices and virtual care solutions enhanced service efficiency and accessibility. The growing integration of AI and IoT in home healthcare further strengthened personalized patient care and chronic disease management.

Mergers and acquisitions played a significant role in market expansion. Companies consolidated to enhance service capabilities. For instance, in March 2025, DispatchHealth and Medically Home merged, forming one of the nation's largest hospital-at-home providers. The merger strengthened their ability to deliver high-acuity care using telehealth, virtual call centres, and in-home devices, benefiting oncology and transplant patients. The home healthcare market continued to grow as regulatory support and technological advancements improved access and affordability.

Regulations significantly impacted the industry by shaping service models and device development.For instance, in April 2024, the FDA launched the "Home as a Health Care Hub" initiative to advance home-based healthcare solutions and health equity. The initiative encouraged medical device manufacturers to design home-specific equipment. It also facilitated collaboration among healthcare providers, patient groups, and developers to improve safety, efficiency, and integration of home-based treatments. Regulatory support accelerates innovation, ensuring that home healthcare continues to evolve as a viable alternative to traditional care settings.

The degree of service expansion in home healthcare increased. Companies broadened their reach through AI, telehealth, and mobile care units. Leading providers invested in remote monitoring and personalized home treatments, ensuring wider access and improved patient outcomes.

Home Healthcare Market Offerings Insights

Based on offerings, the market is divided into equipment and services. The equipment segment comprises therapeutic, diagnostic and monitoring, and mobility assist. Therapeutic equipment includes dialysis, wound care, and IV devices. Diagnostic and monitoring devices encompass blood glucose and pressure monitors, and temperature devices. Mobility assists cover wheelchairs, scooters, and walkers. services include skilled nursing, rehabilitation therapy, hospice and palliative care, respiratory and infusion therapy, and pregnancy care.

The equipment segment is expected to capture a substantial market share. Advanced therapeutic devices, diagnostic and monitoring tools, and mobility assist products drive demand in home healthcare. Rising technological innovations and improved patient outcomes encourage adoption. Manufacturers focus on quality and efficiency to meet evolving needs. Competitive pricing and regulatory support further enhance market penetration. Increasing investments in research and development strengthen product portfolios, fostering growth in this segment across diverse healthcare environments. Globally significant.

Meanwhile, the services segment is experiencing significant growth in the home healthcare market. Increasing demand for personalized care and continuous monitoring drives expansion in Skilled Nursing and Rehabilitation Therapy Services. Hospice, respiratory, and infusion therapy services complement patient needs. Providers are incorporating advanced technologies and telehealth solutions to enhance care delivery. Strategic partnerships and service diversification further boost market potential. An aging population and rising chronic conditions underpin robust demand for comprehensive home healthcare services.

Home Healthcare Market Indication Insights

Based on indication, the market is divided into cancer, respiratory disease, mobility disorders, cardiovascular disease (CVD) and hypertension, pregnancy, wound care, diabetes, hearing disorders, and others. The cancer segment is expected to hold a substantial market share due to the rising global incidence. According to the IARC's 2022 report, 20 million new cancer cases and 9.7 million deaths were recorded worldwide, with lung and breast cancer being the most prevalent. Increasing demand for home-based cancer care, including palliative care and chemotherapy administration, drives market growth. Additionally, the rising need for pain management, rehabilitation, and symptom monitoring at home contributes to the segment's dominance. Advancements in remote monitoring, personalized care plans, and telehealth services further enhance the home healthcare market. Similarly, the CVD & hypertension segment is expanding significantly. In 2021, CVDs caused approximately 20.5 million deaths , representing one-third of global mortality. With nearly one in three adults affected by hypertension worldwide, home monitoring solutions such as blood pressure monitors and telemedicine services are gaining widespread adoption.

Respiratory disease is another common segment in the home healthcare market, driven by the increasing prevalence of conditions such as chronic obstructive pulmonary disease (COPD) and sleep apnea. The rising demand for oxygen therapy, ventilators, and inhalers supports the segment's growth. The growing preference for home-based respiratory care, fueled by cost-effectiveness and comfort, further propels the market. Additionally, the diabetes segment holds a significant share, with approximately 537 million people worldwide affected in 2021, as reported by the IDF. The increasing adoption of insulin delivery devices, blood glucose monitors, and home-based diabetes management solutions drives demand. The growing emphasis on early diagnosis and self-monitoring supports market expansion. Moreover, wound care is a crucial segment, driven by the rising number of surgical procedures and the increasing prevalence of chronic wounds among diabetic and elderly populations.

Other segments, including pregnancy care, mobility disorders, and hearing disorders, contribute significantly to market growth. The pregnancy segment is expanding due to rising awareness of prenatal and postnatal care, increasing demand for fetal monitoring devices, and home-based maternal care solutions. The mobility disorders segment benefits from the rising elderly population and advancements in assistive devices such as wheelchairs, walkers, and mobility scooters. Additionally, the hearing disorders segment is growing due to the rising adoption of home-based hearing aids and tele-audiology services. Overall, the increasing preference for home-based healthcare solutions, technological advancements, and improved patient outcomes drive growth across multiple segments.

Home Healthcare Market Regional Insights

The market includes regions such as North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America leads the market, driven by robust infrastructure, high adoption of AI-powered remote monitoring, and supportive insurance policies. The U.S. and Canada continue to dominate with innovations in home-based care, reducing hospital visits and improving patient outcomes. For instance, in August 2024 , LG Nova (LG Electronics' North America Innovation Center) launched Primefocus Health, an AI-integrated home healthcare platform aimed at enhancing accessibility and efficiency in medical care.

Europe holds a significant share of the home healthcare market due to its aging population, advanced healthcare infrastructure, and strong government support. The region experiences rising demand for home-based care, driven by increasing cases of chronic diseases and a preference for cost-effective treatments. Countries such as Germany, France, and the United Kingdom are expanding the market with a high adoption rate of home healthcare services and equipment. Favourable reimbursement policies and technological advancements further propel market growth. Additionally, telehealth integration and digital health initiatives enhance remote patient monitoring. The growing emphasis on personalized care and improved accessibility continues to strengthen the home healthcare sector across Europe.

In the Asia-Pacific region, rising healthcare demand and technological advancements are fostering market growth. Countries like China and Japan are leading in digital diagnostics, telehealth adoption, and government-driven healthcare initiatives. India home healthcare market is expected to witness growth. In July 2024, Star Health and Allied Insurance launched cashless home healthcare services in 50 Indian cities, covering nursing, lab tests, and physiotherapy. This initiative, in collaboration with key healthcare providers, is improving affordability and accessibility, making home-based care a viable alternative to hospital treatment.

Latin America is also witnessing considerable growth in the home healthcare sector, with Brazil, Mexico, and Argentina leading the way. Increased healthcare awareness, expanding insurance coverage, and rising investments in telemedicine are key drivers. Companies are focusing on digital health solutions to enhance service delivery, with home-based nursing and rehabilitation services becoming more prevalent. The region's growing demand for cost-effective chronic disease management further supports market expansion.

The Middle East and Africa are gradually adopting home healthcare solutions, driven by increasing chronic diseases, aging populations, and government healthcare investments. The UAE home healthcare market is leading in digital healthcare integration, incorporating AI and telehealth into home-based medical services. Expanding home nursing and rehabilitation services are reducing hospital strain while increasing healthcare expenditures continue to drive demand. As technological advancements and policy support grow, home healthcare is becoming an essential component of global healthcare systems.

Home Healthcare Market Key Companies & Market Share Insights

The home healthcare industry is expanding rapidly, fueled by growing demand for remote monitoring, chronic disease management, and cutting-edge medical solutions. Key players are actively collaborating with healthcare providers to enhance patient care and convenience in home settings.

Becton, Dickinson and Company

A pioneer in medical technology since 1897, BD operates from Franklin Lakes, New Jersey. It provides advanced home healthcare solutions. The company's portfolio includes innovative medication delivery systems, diagnostic devices, and speciality catheters, ensuring seamless therapy and improved patient outcomes in home care environments.

Medtronic plc

With a strong presence in home healthcare, Medtronic, founded in 1949 and headquartered in Dublin, Ireland, offers state-of-the-art respiratory monitoring solutions. Its Nellcor SpO? patient monitors, coupled with the OxySoft SpO? Sensor and RespArray Patient Monitor, support continuous, precise respiratory tracking, reinforcing effective home-based care.

Arkray, Inc.

A global leader in diabetes management since 1960, Kyoto-based Arkray has revolutionized self-monitoring with its Glucocard 01 Mini 50 Strips Bottlepack . Designed for the Glucocard 01 Mini glucometer, these strips require minimal blood samples, empowering individuals to efficiently manage diabetes from the comfort of their homes.

Koninklijke Philips N.V.

Koninklijke Philips N.V., headquartered in Amsterdam, Netherlands, and established in 1891, is a key player in the home healthcare market. Through Philips Healthcare@Home, the company provides advanced remote monitoring, ICU@home, respiratory care, palliative care, and rehabilitation services. Philips integrates connected care technology to enhance patient outcomes, reduce hospital visits, and support both chronic and post-acute care at home.

Other players in the market are Fresenius Medical Care ,3M Company ,Abbott ,B Braun Melsungen AG ,F Hoffmann La Roche AG ,ConvaTech Group PLC ,GE HealthCare and ResMed, Inc.

Recent Developments

In March 2025, Dispatch Health and Medically Home merged to create the nation's most comprehensive home healthcare platform. This advancement expands hospital-level care at home, increasing access, lowering costs, and improving patient outcomes across major metropolitan areas.
In July 2024, Lifetime Health secured USD 1.5 million seed funding led by The Garage Syndicate. The Bengaluru-based startup aims to boost its digital home healthcare platform, expand services, and scale across new cities with advanced automation and telehealth features.
In August 2024, Vivid Health introduced a generative AI solution in home healthcare. The innovation streamlines OASIS form completion, reducing staff burnout and boosting efficiency. This advancement enhances hospital-at-home services and addresses high staff turnover.
In April 2024, the FDA launched a new initiative titled Home as a Health Care Hub. The program supports innovative home healthcare models and devices, aiming to enhance health equity. It fosters collaboration among providers, patient groups, and developers.
In April 2024, Air Liquide acquired Homecare activities in Belgium and the Netherlands, strengthening its global home healthcare presence. The acquisition broadens Air Liquide's market footprint, enhancing support for patients with respiratory, sleep apnea, and infusion needs across these regions.
In February 2024, GE HealthCare and Biofourmis launched innovative virtual care-at-home solutions to extend patient monitoring beyond hospitals. Their collaboration strengthens continuity of care, reduces readmission rates, and enhances patient satisfaction across the home healthcare continuum.
In October 2023, HCG Cancer Centre Nagpur launched a comprehensive home healthcare service for cancer patients. The initiative, featuring nursing, cancer screening, lab tests, and medicine delivery, exemplifies recent market advancements and reinforces patient dignity and independence.
In September 2023, Merago partnered with Portea Medical to launch advanced home healthcare services in India. The collaboration introduces a cutting-edge digital platform delivering comprehensive personal healthcare management and technology-driven solutions for in-home treatments, including chemotherapy and dialysis.

Home Healthcare Market Report Segmentation

Home Healthcare Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Offerings Outlook

Equipment
?? Therapeutic Dialysis Equipment Wound Care Products IV Equipment Sleep Apnea Therapeutic Devices Insulin Delivery Devices Oxygen Delivery Systems Inhalers Ventilators Others
?? Diagnostic and Monitoring Blood Glucose Monitors Blood Pressure Monitors Temperature Monitoring Device Ovulation & Pregnancy Test Kits Pulse Oximeters Drug and Alcohol Test Kits Home Sleep Testing Devices Cholesterol Testing Products ECG Devices Home Hemoglobin A1C Test Kits Others
?? Mobility Assist Wheelchair Mobility Scooters Walkers and Rollators Crutches Others

Services

?? Skilled Nursing Services
?? Rehabilitation Therapy Services
?? Hospice and Palliative Care Services
?? Respiratory Therapy Services
?? Infusion Therapy Services
?? Pregnancy Care Services
?? Others

Indication Outlook

Cancer
Respiratory Disease
Mobility Disorders
CVD & Hypertension
Pregnancy
Wound Care
Diabetes
Hearing Disorders
Others

Regional Outlook

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Home Healthcare Market Overview
3.1 Global Home Healthcare Market Historical Value (2018-2024)
3.2 Global Home Healthcare Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Home Healthcare Market Landscape*
5.1 Global Home Healthcare Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Home Healthcare Market: Product Landscape
5.2.1 Analysis by Offerings
5.2.2 Analysis by Indication
6 Global Home Healthcare Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Home Healthcare Market Segmentation (218-2034)
7.1 Global Home Healthcare Market (2018-2034) by Offerings
7.1.1 Market Overview
7.1.2 Equipment
7.1.2.1 Therapeutic
7.1.2.1.1 Dialysis Equipment
7.1.2.1.2 Wound Care Products
7.1.2.1.3 IV Equipment
7.1.2.1.4 Sleep Apnea Therapeutic Devices
7.1.2.1.5 Insulin Delivery Devices
7.1.2.1.6 Oxygen Delivery Systems
7.1.2.1.7 Inhalers
7.1.2.1.8 Ventilators
7.1.2.1.9 Others
7.1.2.2 Diagnostic and Monitoring
7.1.2.2.1 Blood Glucose Monitors
7.1.2.2.2 Blood Pressure Monitors
7.1.2.2.3 Temperature Monitoring Device
7.1.2.2.4 Ovulation & Pregnancy Test Kits
7.1.2.2.5 Pulse Oximeters
7.1.2.2.6 Drug and Alcohol Test Kits
7.1.2.2.7 Home Sleep Testing Devices
7.1.2.2.8 Cholesterol Testing Products
7.1.2.2.9 ECG Devices
7.1.2.2.10 Home Hemoglobin A1C Test Kits
7.1.2.2.11 Others
7.1.2.3 Mobility Assist
7.1.2.3.1 Wheelchair
7.1.2.3.2 Mobility Scooters
7.1.2.3.3 Walkers and Rollators
7.1.2.3.4 Crutches
7.1.2.3.5 Others
7.1.3 Services
7.1.3.1 Skilled Nursing Services
7.1.3.2 Rehabilitation Therapy Services
7.1.3.3 Hospice and Palliative Care Services
7.1.3.4 Respiratory Therapy Services
7.1.3.5 Infusion Therapy Services
7.1.3.6 Pregnancy Care Services
7.1.3.7 Others
7.2 Global Home Healthcare Market (2018-2034) by Indication
7.2.1 Market Overview
7.2.2 Cancer
7.2.3 Respiratory Disease
7.2.4 Mobility Disorders
7.2.5 CVD & Hypertension
7.2.6 Pregnancy
7.2.7 Wound Care
7.2.8 Diabetes
7.2.9 Hearing Disorders
7.2.10 Others
7.3 Global Home Healthcare Market (2018-2034) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Home Healthcare Market (218-2034)
8.1 North America Home Healthcare Market (2018-2034) by Offerings
8.1.1 Market Overview
8.1.2 Reagents
8.1.2.1 Antibodies
8.1.2.2 Magnetic Beads
8.1.2.3 Histones
8.1.2.4 Buffers
8.1.2.5 Primers
8.1.2.6 Others
8.1.3 Kits
8.1.3.1 ChIP sequencing kit
8.1.3.2 Whole Genomic Amplification kit
8.1.3.3 Bisulfite Conversion kit
8.1.3.4 RNA sequencing kit
8.1.3.5 Others
8.1.4 Instruments
8.1.4.1 Next generation sequencers
8.1.4.2 qPCRs
8.1.4.3 Mass Spectrometers
8.1.4.4 Sonicators
8.1.4.5 Others
8.1.5 Enzymes
8.1.5.1 DNA Polymerases
8.1.5.2 DNA Ligases
8.1.5.3 Methyltransferases
8.1.5.4 Acetylases
8.1.5.5 Reverse Transcriptase
8.1.5.6 Others
8.1.6 Services
8.2 North America Home Healthcare Market (2018-2034) by Application
8.2.1 Market Overview
8.2.1.1 Oncology
8.2.1.1.1 Solid tumors
8.2.1.1.2 Liquid tumors
8.2.1.2 Non-oncology oncology
8.2.1.2.1 Inflammatory diseases
8.2.1.2.2 Metabolic diseases
8.2.1.2.3 Infectious diseases
8.2.1.2.4 Cardiovascular diseases
8.2.1.2.5 Others
8.3 North America Home Healthcare Market (2018-2034) by End User
8.3.1 Market Overview
8.3.2 Pharmaceutical & Biotechnology Companies
8.3.3 Hospitals & Clinics
8.3.4 Academic and Research Institutes
8.3.5 Clinical Research
8.3.6 Others
8.4 North America Home Healthcare Market (2018-2034) by Country
8.4.1 United States of America
8.4.1.1 United States of America Home Healthcare Market (2018-2034) by Offerings
8.4.2 Canada
8.4.2.1 Canada Home Healthcare Market (2018-2034) by Offerings
9 Europe Home Healthcare Market (218-2034)
9.1 Europe Home Healthcare Market (2018-2034) by Offerings
9.1.1 Market Overview
9.1.2 Reagents
9.1.2.1 Antibodies
9.1.2.2 Magnetic Beads
9.1.2.3 Histones
9.1.2.4 Buffers
9.1.2.5 Primers
9.1.2.6 Others
9.1.3 Kits
9.1.3.1 ChIP sequencing kit
9.1.3.2 Whole Genomic Amplification kit
9.1.3.3 Bisulfite Conversion kit
9.1.3.4 RNA sequencing kit
9.1.3.5 Others
9.1.4 Instruments
9.1.4.1 Next generation sequencers
9.1.4.2 qPCRs
9.1.4.3 Mass Spectrometers
9.1.4.4 Sonicators
9.1.4.5 Others
9.1.5 Enzymes
9.1.5.1 DNA Polymerases
9.1.5.2 DNA Ligases
9.1.5.3 Methyltransferases
9.1.5.4 Acetylases
9.1.5.5 Reverse Transcriptase
9.1.5.6 Others
9.1.6 Services
9.2 Europe Home Healthcare Market (2018-2034) by Application
9.2.1 Market Overview
9.2.1.1 Oncology
9.2.1.1.1 Solid tumors
9.2.1.1.2 Liquid tumors
9.2.1.2 Non-oncology oncology
9.2.1.2.1 Inflammatory diseases
9.2.1.2.2 Metabolic diseases
9.2.1.2.3 Infectious diseases
9.2.1.2.4 Cardiovascular diseases
9.2.1.2.5 Others
9.3 Europe Home Healthcare Market (2018-2034) by End User
9.3.1 Market Overview
9.3.2 Pharmaceutical & Biotechnology Companies
9.3.3 Hospitals & Clinics
9.3.4 Academic and Research Institutes
9.3.5 Clinical Research
9.3.6 Others
9.4 Europe Home Healthcare Market (2018-2034) by Country
9.4.1 United Kingdom
9.4.1.1 United Kingdom Home Healthcare Market (2018-2034) by Offerings
9.4.2 Germany
9.4.2.1 Germany Home Healthcare Market (2018-2034) by Offerings
9.4.3 France
9.4.3.1 France Home Healthcare Market (2018-2034) by Offerings
9.4.4 Italy
9.4.4.1 Italy Home Healthcare Market (2018-2034) by Offerings
9.4.5 Others
10 Asia Pacific Home Healthcare Market (218-2034)
10.1 Asia Pacific Home Healthcare Market (2018-2034) by Offerings
10.1.1 Market Overview
10.1.2 Reagents
10.1.2.1 Antibodies
10.1.2.2 Magnetic Beads
10.1.2.3 Histones
10.1.2.4 Buffers
10.1.2.5 Primers
10.1.2.6 Others
10.1.3 Kits
10.1.3.1 ChIP sequencing kit
10.1.3.2 Whole Genomic Amplification kit
10.1.3.3 Bisulfite Conversion kit
10.1.3.4 RNA sequencing kit
10.1.3.5 Others
10.1.4 Instruments
10.1.4.1 Next generation sequencers
10.1.4.2 qPCRs
10.1.4.3 Mass Spectrometers
10.1.4.4 Sonicators
10.1.4.5 Others
10.1.5 Enzymes
10.1.5.1 DNA Polymerases
10.1.5.2 DNA Ligases
10.1.5.3 Methyltransferases
10.1.5.4 Acetylases
10.1.5.5 Reverse Transcriptase
10.1.5.6 Others
10.1.6 Services
10.2 Asia Pacific Home Healthcare Market (2018-2034) by Application
10.2.1 Market Overview
10.2.1.1 Oncology
10.2.1.1.1 Solid tumors
10.2.1.1.2 Liquid tumors
10.2.1.2 Non-oncology oncology
10.2.1.2.1 Inflammatory diseases
10.2.1.2.2 Metabolic diseases
10.2.1.2.3 Infectious diseases
10.2.1.2.4 Cardiovascular diseases
10.2.1.2.5 Others
10.3 Asia Pacific Home Healthcare Market (2018-2034) by End User
10.3.1 Market Overview
10.3.2 Pharmaceutical & Biotechnology Companies
10.3.3 Hospitals & Clinics
10.3.4 Academic and Research Institutes
10.3.5 Clinical Research
10.3.6 Others
10.4 Asia Pacific Home Healthcare Market (2018-2034) by Country
10.4.1 China
10.4.1.1 China Home Healthcare Market (2018-2034) by Offerings
10.4.2 Japan
10.4.2.1 Japan Home Healthcare Market (2018-2034) by Offerings
10.4.3 India
10.4.3.1 India Home Healthcare Market (2018-2034) by Offerings
10.4.4 ASEAN
10.4.4.1 ASEAN Home Healthcare Market (2018-2034) by Offerings
10.4.5 Australia
10.4.5.1 Australia Home Healthcare Market (2018-2034) by Offerings
10.4.6 Others
11 Latin America Home Healthcare Market (218-2034)
11.1 Latin America Home Healthcare Market (2018-2034) by Offerings
11.1.1 Market Overview
11.1.2 Reagents
11.1.2.1 Antibodies
11.1.2.2 Magnetic Beads
11.1.2.3 Histones
11.1.2.4 Buffers
11.1.2.5 Primers
11.1.2.6 Others
11.1.3 Kits
11.1.3.1 ChIP sequencing kit
11.1.3.2 Whole Genomic Amplification kit
11.1.3.3 Bisulfite Conversion kit
11.1.3.4 RNA sequencing kit
11.1.3.5 Others
11.1.4 Instruments
11.1.4.1 Next generation sequencers
11.1.4.2 qPCRs
11.1.4.3 Mass Spectrometers
11.1.4.4 Sonicators
11.1.4.5 Others
11.1.5 Enzymes
11.1.5.1 DNA Polymerases
11.1.5.2 DNA Ligases
11.1.5.3 Methyltransferases
11.1.5.4 Acetylases
11.1.5.5 Reverse Transcriptase
11.1.5.6 Others
11.1.6 Services
11.2 Latin America Home Healthcare Market (2018-2034) by Application
11.2.1 Market Overview
11.2.1.1 Oncology
11.2.1.1.1 Solid tumors
11.2.1.1.2 Liquid tumors
11.2.1.2 Non-oncology oncology
11.2.1.2.1 Inflammatory diseases
11.2.1.2.2 Metabolic diseases
11.2.1.2.3 Infectious diseases
11.2.1.2.4 Cardiovascular diseases
11.2.1.2.5 Others
11.3 Latin America Home Healthcare Market (2018-2034) by End User
11.3.1 Market Overview
11.3.2 Pharmaceutical & Biotechnology Companies
11.3.3 Hospitals & Clinics
11.3.4 Academic and Research Institutes
11.3.5 Clinical Research
11.3.6 Others
11.4 Latin America Home Healthcare Market (2018-2034) by Country
11.4.1 Brazil
11.4.1.1 Brazil Home Healthcare Market (2018-2034) by Offerings
11.4.2 Argentina
11.4.2.1 Argentina Home Healthcare Market (2018-2034) by Offerings
11.4.3 Mexico
11.4.3.1 Mexico Home Healthcare Market (2018-2034) by Offerings
11.4.4 Others
12 Middle East and Africa Home Healthcare Market (218-2034)
12.1 Middle East and Africa Home Healthcare Market (2018-2034) by Offerings
12.1.1 Market Overview
12.1.2 Reagents
12.1.2.1 Antibodies
12.1.2.2 Magnetic Beads
12.1.2.3 Histones
12.1.2.4 Buffers
12.1.2.5 Primers
12.1.2.6 Others
12.1.3 Kits
12.1.3.1 ChIP sequencing kit
12.1.3.2 Whole Genomic Amplification kit
12.1.3.3 Bisulfite Conversion kit
12.1.3.4 RNA sequencing kit
12.1.3.5 Others
12.1.4 Instruments
12.1.4.1 Next generation sequencers
12.1.4.2 qPCRs
12.1.4.3 Mass Spectrometers
12.1.4.4 Sonicators
12.1.4.5 Others
12.1.5 Enzymes
12.1.5.1 DNA Polymerases
12.1.5.2 DNA Ligases
12.1.5.3 Methyltransferases
12.1.5.4 Acetylases
12.1.5.5 Reverse Transcriptase
12.1.5.6 Others
12.1.6 Services
12.2 Middle East and Africa Home Healthcare Market (2018-2034) by Application
12.2.1 Market Overview
12.2.1.1 Oncology
12.2.1.1.1 Solid tumors
12.2.1.1.2 Liquid tumors
12.2.1.2 Non-oncology oncology
12.2.1.2.1 Inflammatory diseases
12.2.1.2.2 Metabolic diseases
12.2.1.2.3 Infectious diseases
12.2.1.2.4 Cardiovascular diseases
12.2.1.2.5 Others
12.3 Middle East and Africa Home Healthcare Market (2018-2034) by End User
12.3.1 Market Overview
12.3.2 Pharmaceutical & Biotechnology Companies
12.3.3 Hospitals & Clinics
12.3.4 Academic and Research Institutes
12.3.5 Clinical Research
12.3.6 Others
12.4 Middle East and Africa Home Healthcare Market (2018-2034) by Country
12.4.1 Saudi Arabia
12.4.1.1 Saudi Arabia Home Healthcare Market (2018-2034) by Offerings
12.4.2 United Arab Emirates
12.4.2.1 United Arab Emirates Home Healthcare Market (2018-2034) by Offerings
12.4.3 Nigeria
12.4.3.1 Nigeria Home Healthcare Market (2018-2034) by Offerings
12.4.4 South Africa
12.4.4.1 South Africa Home Healthcare Market (2018-2034) by Offerings
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Initiatives
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia Pacific
16.1.5 Market Share Analysis: Others
16.2 Becton, Dickinson and Company
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Fresenius Medical Care
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Medtronic plc
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 3M Company
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Abbott
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 B Braun Melsungen AG
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Arkray, Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 F Hoffmann La Roche AG
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 ConvaTech Group PLC
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 GE HealthCare
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Koninklijke Philips N.V.
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 ResMed, Inc.
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Global Home Healthcare Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE